Anaheim Ducks Captain Ryan Getzlaf Will Host 5th Annual Getzlaf Golf Shootout To Support CareDuchenne

Isaura Santos avatar

by Isaura Santos |

Share this article:

Share article via email
Ryan Getzlaf DMD golf tournament

The 5th Annual Getzlaf Golf Shootout to benefit CureDuchenne will take place on September 12th at Sutra Lounge in Costa Mesa, California and September 13th at the Monarch Beach Golf Links in Dana Point, California. The event will be hosted by the captain of the Anaheim DucksRyan Getzlaf. The Getzlaf Golf Shootout is a 2-day charity golf event to bring together celebrities, athletes and community leaders, all partnering to support CureDuchenne.

Each foursome in the golf shootout includes a celebrity or a professional athlete who serves as a special 5th player. Past and current Anaheim Ducks coaches and teammates includes Bruce Boudreau, Scott Neidermayer, Teemu Selanne, Ryan Kesler, Corey Perry, Andrew Cogliano, Frederik Andersen, Mark Fistric, Tim Jackman, Clayton Stoner, Brian Sutherby, Dany Heatley, Kent Huskins, Bob Murray, Andy Sutton and Emerson Etem that have played in past tournaments.

CureDuchenne is a nonprofit organization focused on raising awareness and funds to support research and ultimately find a cure for Duchenne muscular dystrophy. DMD is a progressive disease of the muscles that affects 1 in every 3,500 boys and over 300,000 boys worldwide. The diagnosis for DMD is usually made around the age of 5, and by 12 years old patients are usually required to use a wheelchair. The majority of DMD patients pass away in their mid 20s. There is no cure for Duchenne Muscular Dystrophy, which emphasizes the urgency and the relevance of the event. Proceeds from the Getzlaf Golf Shootout will be used to fund research that might lead to a cure.

The event’s sponsors include Patriot Environmental Services, Bauer, CNC Motors, Gateway One Lending, Fullmer Construction, Mark Beamish Waterproofing and The Sports Corporation. For information regarding sponsorship, visit

Other Recent News
A new collaborative group involving academic and industry researchers and patient advocacy groups conducted a large-scale study to find serum biomarkers for Duchenne muscular dystrophy (DMD). The study was recently published in the journal Proceedings of the National Academy of Sciences (PNAS) and is entitled “Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy.”